ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 265 out of 2094

$373K Total Retail Price of All Prescriptions

Rank: 780 out of 2094

341 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 341 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 463 352 1 1
AMLODIPINE BESYLATE 384 277 2 2
OMEPRAZOLE 373 266 3 4
METFORMIN HCL 313 202 4 8
LISINOPRIL 299 229 5 7
PROAIR HFA 286 191 6 45
IBUPROFEN 215 81 7 73
ZOLPIDEM TARTRATE 214 136 8 14
METOPROLOL SUCCINATE 196 147 9 9
MELOXICAM 194 167 10 49
ENALAPRIL MALEATE 189 123 11 25
FUROSEMIDE 170 145 12 6
METOPROLOL TARTRATE 165 130 13 10
DONEPEZIL HCL 159 159 14 20
ATORVASTATIN CALCIUM 151 125 15 5
LEVOTHYROXINE SODIUM 148 105 16 3
TRAMADOL HCL 147 100 17 33
LANTUS 130 96 18 66
CLOPIDOGREL 108 80 19 22
CARVEDILOL 107 94 20 19
WARFARIN SODIUM 106 85 21 11
AZITHROMYCIN 105 74 22 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 83 23 55
ALENDRONATE SODIUM 93 71 24 30
DIOVAN 91 78 25 13
DIOVAN HCT 88 63 26 28
PLAVIX 84 68 27 38
TRAMADOL HCL-ACETAMINOPHEN 83 51 28 100
METFORMIN HCL ER 78 66 29 67
HYDROCHLOROTHIAZIDE 75 43 30 12
VENTOLIN HFA 74 42 31 132
NOVOLOG 71 58 32 116
LANTUS SOLOSTAR 70 50 33 76
CRESTOR 66 51 34 15
LOSARTAN POTASSIUM 66 56 34 17
RISPERIDONE 64 64 36 56
GLIPIZIDE XL 62 44 37 122
DIGOXIN 62 53 37 51
OXYCODONE-ACETAMINOPHEN 60 49 S2 39 40
PANTOPRAZOLE SODIUM 59 50 40 37
SERTRALINE HCL 52 35 41 26
LACTULOSE 52 25 41 65
MIRTAZAPINE 51 31 43 43
ADVAIR DISKUS 50 35 44 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.